Similar Articles
101 Hepatitis C virus infection: Are there still specific problems with genotype 3?
102 Is liver biopsy still needed in children with chronic viral hepatitis?
103 Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients
104 Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes
105 Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand
106 Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection
107 Assessing cardiovascular risk in hepatitis C: An unmet need
108 Epidemiology of hepatitis C in Croatia in the European context
109 Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients
110 Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA